0001209191-23-055436.txt : 20231115
0001209191-23-055436.hdr.sgml : 20231115
20231115201453
ACCESSION NUMBER: 0001209191-23-055436
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231110
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vig Pamela
CENTRAL INDEX KEY: 0001780069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 231412175
MAIL ADDRESS:
STREET 1: C/O MIRUM PHARMACEUTICALS, INC.
STREET 2: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-10
0
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001780069
Vig Pamela
C/O MIRUM PHARMACEUTICALS, INC.
950 TOWER LANE, SUITE 1050
FOSTER CITY
CA
94404
0
1
0
0
Head of Research & Development
0
Common Stock
2023-11-10
5
A
0
E
527
22.287
A
31313
D
Common Stock
75000
I
By The Vig-Ancock Family Trust
This Form 4 is being filed voluntarily to report the acquisition of 527 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.
/s/ Judit Ryvkin, Attorney-in-Fact
2023-11-15